UnknownPhase 4

Treatment of Mild and Subthreshold Depressive Disorders

Germany369 participants

Plain-language summary

The purpose of this study is to determine the efficacy of a SSRI, cognitive-bahavioral-therapy and a free choice between SSRI and CBT in a sample of primary care patients suffering from mild to moderate depression. Hypotheses: * SSRI is superior to placebo * CBT is superior to a non-specific supporting group therapy

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria:(e.g.) * subthreshold and mild depressive disorders including dysthymia (HAMD: 8-22) * informed consent * 18 years Exclusion Criteria:(e.g.) * severe mood disorders * bipolar disorder * recurrent brief depression * suicidality * alcohol or drug dependency * obsessive-compulsive disorder * schizoaffective disorder / schizophrenia * pregnancy

What they're measuring

HAMD (changes between baseline and individual endpoint)

IDS (changes between baseline and individual endpoint)

Trial details

NCT IDNCT00226642

SponsorLudwig-Maximilians - University of Munich

Sponsor typeOTHER

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Depression trials